{"id":"W2116183806","doi":"10.1016/s1470-2045(12)70567-3","title":"Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; McMaster University","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Bevacizumab; Medicine; Ovarian cancer; Carboplatin; Clinical endpoint; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Oncology; Chemotherapy; Endometrial cancer; Gynecologic oncology; Cancer; Clinical trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067756,0.001369432,0.003279741,0.0003865763,0.00035266,0.001115151,0.0007102137,0.001602444,0.00474068],"category_scores_gemma":[0.0027868,0.0004233911,0.004352667,0.0005541774,0.0008708611,0.001001418,0.0007559431,0.003272331,0.0004411751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001629971,"about_ca_system_score_gemma":0.00114408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00278387,"about_ca_topic_score_gemma":0.006447393,"domain_scores_codex":[0.9987804,0.0007208242,0.00009127335,0.0001696962,0.00008366701,0.0001539971],"domain_scores_gemma":[0.998623,0.0004660556,0.0003872469,0.0001137165,0.00008469958,0.0003252932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9810193,0.0007294446,0.000983607,0.001018664,0.004580425,0.00001557004,0.00002569711,0.0004837964,0.0005576445,0.0001510342,0.001286469,0.009148326],"study_design_scores_gemma":[0.9727497,0.01705369,0.004548398,0.0001609652,0.003823941,0.00002441929,0.00002728137,0.0003134616,0.0001325036,0.0003856595,0.0007609233,0.00001900801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9583783,0.02752401,0.0009041155,0.002112294,0.001302678,0.002279039,0.003231543,0.00009495425,0.004173101],"genre_scores_gemma":[0.9856742,0.004736813,0.001078815,0.001762655,0.0004324309,0.001895569,0.002611839,0.00002487335,0.001782888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00474068,"threshold_uncertainty_score":0.01585919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07110357242492646,"score_gpt":0.4109774263119079,"score_spread":0.3398738538869814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}